KR102530966B1 - 치주염 백신 및 관련 조성물 및 사용 방법 - Google Patents

치주염 백신 및 관련 조성물 및 사용 방법 Download PDF

Info

Publication number
KR102530966B1
KR102530966B1 KR1020207013299A KR20207013299A KR102530966B1 KR 102530966 B1 KR102530966 B1 KR 102530966B1 KR 1020207013299 A KR1020207013299 A KR 1020207013299A KR 20207013299 A KR20207013299 A KR 20207013299A KR 102530966 B1 KR102530966 B1 KR 102530966B1
Authority
KR
South Korea
Prior art keywords
vaccine formulation
antigen sequence
ala
gly
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207013299A
Other languages
English (en)
Korean (ko)
Other versions
KR20200070302A (ko
Inventor
제프리 페어맨
Original Assignee
박사이트, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박사이트, 인코포레이티드 filed Critical 박사이트, 인코포레이티드
Priority to KR1020237015301A priority Critical patent/KR20230066660A/ko
Publication of KR20200070302A publication Critical patent/KR20200070302A/ko
Application granted granted Critical
Publication of KR102530966B1 publication Critical patent/KR102530966B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1020207013299A 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법 Active KR102530966B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020237015301A KR20230066660A (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762571582P 2017-10-12 2017-10-12
US62/571,582 2017-10-12
PCT/US2018/055496 WO2019075260A1 (en) 2017-10-12 2018-10-11 VACCINE AGAINST PERIODONTITIS AND ASSOCIATED COMPOSITIONS AND METHOD OF USE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020237015301A Division KR20230066660A (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법

Publications (2)

Publication Number Publication Date
KR20200070302A KR20200070302A (ko) 2020-06-17
KR102530966B1 true KR102530966B1 (ko) 2023-05-15

Family

ID=64110091

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020207013299A Active KR102530966B1 (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법
KR1020237015301A Ceased KR20230066660A (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020237015301A Ceased KR20230066660A (ko) 2017-10-12 2018-10-11 치주염 백신 및 관련 조성물 및 사용 방법

Country Status (14)

Country Link
US (3) US10835590B2 (cg-RX-API-DMAC7.html)
EP (1) EP3694547A1 (cg-RX-API-DMAC7.html)
JP (2) JP7258870B2 (cg-RX-API-DMAC7.html)
KR (2) KR102530966B1 (cg-RX-API-DMAC7.html)
CN (1) CN111225684A (cg-RX-API-DMAC7.html)
AU (1) AU2018347511A1 (cg-RX-API-DMAC7.html)
CA (1) CA3078630A1 (cg-RX-API-DMAC7.html)
EA (1) EA202090908A1 (cg-RX-API-DMAC7.html)
IL (1) IL273690A (cg-RX-API-DMAC7.html)
MA (1) MA50363A (cg-RX-API-DMAC7.html)
MX (1) MX2020003810A (cg-RX-API-DMAC7.html)
PH (1) PH12020550239A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202003147XA (cg-RX-API-DMAC7.html)
WO (1) WO2019075260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111225684A (zh) 2017-10-12 2020-06-02 Sutrovax公司 牙周炎疫苗和相关组合物及使用方法
US12637503B2 (en) 2020-11-03 2026-05-26 K-Bio Investment, Llc Antigen-binding molecules that bind to Porphyromonas gingivalis
WO2025019900A1 (en) * 2023-07-26 2025-01-30 Denteric Pty Ltd Chimeric protein vaccine
CN116751292B (zh) * 2023-07-31 2024-05-14 河南大学 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047961A1 (en) 1999-12-24 2001-07-05 Csl Limited P. gingivalis antigenic composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59128338A (ja) 1982-12-08 1984-07-24 Kitasato Inst:The 歯周炎予防用ワクチン及びその製法
WO1994028014A2 (en) 1993-05-28 1994-12-08 Chiron Corporation Peptide inhibitors of urokinase receptor activity
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
JP2000507245A (ja) 1996-03-22 2000-06-13 ユニバーシティー オブ ジョージア リサーチ ファウンデーション,インコーポレイテッド Porphyromonas gingivalisペプチドを含む免疫原性組成物および方法
US6833262B1 (en) 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
AUPQ065299A0 (en) 1999-05-28 1999-06-24 University Of Sydney, The A method of prophylaxis and treatment and agents useful for same
US7378101B2 (en) 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
GB0411150D0 (en) 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
MX2012001495A (es) 2009-08-02 2012-08-03 Sanofi Pasteur Ltd Polipeptidos de porphyromonas gingivalis.
AU2011214908A1 (en) 2010-02-12 2012-09-20 Sydney West Area Health Services (Swahs) Protein domains and uses therefor
WO2011130544A2 (en) 2010-04-14 2011-10-20 Sutro Biopharma, Inc. Monitoring a dynamic system by liquid chromatography-mass spectrometry
WO2014058830A1 (en) 2012-10-12 2014-04-17 Sutro Biopharma, Inc. Proteolytic inactivation of select proteins in bacterial extracts for improved expression
EP3365027B1 (en) * 2015-10-14 2022-03-30 Research Institute at Nationwide Children's Hospital Hu specific antibodies and their use in inhibiting biofilm
CN111225684A (zh) 2017-10-12 2020-06-02 Sutrovax公司 牙周炎疫苗和相关组合物及使用方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047961A1 (en) 1999-12-24 2001-07-05 Csl Limited P. gingivalis antigenic composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PLOS ONE, 제6권, 제10호, e26163(2011.10.14.)
Vaccine, 제34권, 제38호, 4626-4634면(2016.7.25.)

Also Published As

Publication number Publication date
US11701414B2 (en) 2023-07-18
CA3078630A1 (en) 2019-04-18
WO2019075260A1 (en) 2019-04-18
EA202090908A1 (ru) 2020-10-29
IL273690A (en) 2020-05-31
US20190192645A1 (en) 2019-06-27
JP2020536925A (ja) 2020-12-17
US20240131134A1 (en) 2024-04-25
PH12020550239A1 (en) 2021-02-15
US20210361756A1 (en) 2021-11-25
JP7258870B2 (ja) 2023-04-17
KR20230066660A (ko) 2023-05-16
MA50363A (fr) 2020-08-19
AU2018347511A1 (en) 2020-05-21
EP3694547A1 (en) 2020-08-19
US10835590B2 (en) 2020-11-17
KR20200070302A (ko) 2020-06-17
AU2018347511A8 (en) 2020-06-11
CN111225684A (zh) 2020-06-02
BR112020006500A2 (pt) 2020-10-13
US20240226259A9 (en) 2024-07-11
SG11202003147XA (en) 2020-05-28
JP2023098935A (ja) 2023-07-11
US12121575B2 (en) 2024-10-22
MX2020003810A (es) 2020-08-13

Similar Documents

Publication Publication Date Title
US12121575B2 (en) Periodontitis vaccine and related compositions and methods of use
US10947280B2 (en) UspA2 protein constructs and uses thereof
KR101721904B1 (ko) P.진지발리스 감염의 예방, 치료 및 진단
JP7847091B2 (ja) 肺炎桿菌o抗原ワクチン
JP5627581B2 (ja) ソマトスタチン免疫原性増進のための組成物および方法
CN102488898B (zh) 龋齿疫苗及制备方法
EP4466013A1 (en) Chimeric polypeptides
WO2023137519A1 (en) Chimeric polypeptides
US10933126B2 (en) Clostridium difficile immunogenic compositions and methods of use
JP2022527206A (ja) 侵入プラスミド抗原bの最適化された無細胞合成、および関連する組成物、および使用方法
EA044863B1 (ru) Вакцина и связанные композиции для лечения пародонтита и способ применения
BR112020006500B1 (pt) Composição imunogênica e seus usos, formulação de vacina e usos de um polipeptídeo para fabricação de uma composição imunogênica
CN102772792B (zh) 一种预防龋齿的疫苗及其制备方法
WO2011033319A1 (en) Commensal neisserial stress protein preparations
EA050190B1 (ru) Оптимизированный бесклеточный синтез плазмидного антигена инвазии в и родственные композиции и способы применения
WO2025019900A1 (en) Chimeric protein vaccine
KR20160049875A (ko) 플라젤린 및 치주 질환 유발 병원체의 단백질을 포함하는 재조합 융합 단백질 및 이의 용도

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601